+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biorefineries

  • ID: 2784225
  • Book
  • 296 Pages
  • Elsevier Science and Technology
1 of 4

Biorefineries outlines the processes and steps to successfully scale up production of two types of biofuels, butanol and ethanol, from cellulosic residues for commercial purposes. It covers practical topics, including biomass availability, pretreatment, fermentation, and water recycling, as well as policy and economic factors. This reflects the unique expertise of the editor team, whose backgrounds range from wood and herbaceous feedstocks to process economics and industrial expertise. The strategies presented in this book help readers to design integrated and efficient processes to reduce the cost of production and achieve an economically viable end product

  • Outlines the economic benefits of designing a single operational process.
  • Includes all currently available processes on pretreatment, fermentation and recovery
  • Covers all pretreatment, fermentation, and product recovery options
  • Focuses on biofuels but acts as a stepping stone to develop cost-efficient processes for an array of commodity chemicals
Note: Product cover images may vary from those shown
2 of 4

PART I CELLULOSIC BIOMASS PROCESSING & BIOREFINERY ROAD MAP

CHAPTER 1 An Overview of Existing Individual Unit Operations

CHAPTER 2 Biomass for Biorefining: Resources, Allocation, Utilization, and Policies

CHAPTER 3 Biorefinery Roadmaps

CHAPTER 4 Integration of (Hemi)-Cellulosic Biofuels Technologies with Chemical Pulp Production

CHAPTER 5 Integrated Processes for Product Recovery

PART II CELLULOSIC ETHANOL

CHAPTER 6 Development of Growth-Arrested Bioprocesses with Corynebacterium glutamicum for Cellulosic Ethanol Production from Complex Sugar Mixtures

CHAPTER 7 Consolidated Bioprocessing for Ethanol Production

CHAPTER 8 Integration of Ethanol Fermentation with Second Generation Biofuels Technologies

PART III CELLULOSIC BUTANOL

CHAPTER 9 Mixed Sugar Fermentation by Clostridia and Metabolic Engineering for Butanol Production

CHAPTER 10 Integrated Bioprocessing and Simultaneous Product Recovery for Butanol Production

CHAPTER 11 Integrated Production of Butanol from Glycerol

PART IV PROCESS ECONOMICS & FARM-BASED BIOREFINERY

CHAPTER 12 Process Economics of Renewable Biorefineries: Butanol and Ethanol Production in Integrated Bioprocesses from Lignocellulosics and Other Industrial By-Products

CHAPTER 13 Integrated Farm-Based Biorefinery

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Qureshi, Nasib
US Department of Agriculture, National Center for Agricultural Utilization Research, Bioenergy Research Unit, Peoria, IL US
US Department of Agriculture, National Center for Agricultural Utilization Research, Peoria, IL US
. Senior Researcher/Senior Scientist, United States Department of Agriculture, National Center for Agricultural Utilization Research, Bioenergy Research Unit.
. Affiliate Faculty, Institute for Genomic Biology, Univ. of Illinois.
. Adjunct Professor (Biochemical Engineering), University of Illinois.
. EIC, World Journal of Microbiology & Biotechnology (Springer).
. Co-Editor, Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies (Wiley, 2015).
Hodge, David
Michigan State University, MI USA
Vertes, Alain
University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flanders-Artois

. Sloan Fellow from London Business School and a microbiologist by training (University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flandres-Artois).

. Consulting, Partnering & Fund Raising, Founder, Managing Director, NxR Biotechnologies, Switzerland.

. Dr. Vertès is a strategy and business development consultant for cell therapeutic biotech companies, and works to enable seed funding in the field. Focusing on technology deployment and innovation commercialization, he has contributed to both industrial and pharmaceutical biotechnology, in different functions including research, manufacturing, contract research, and strategic alliances in pharmaceuticals (Lilly, Pfizer, Roche).

. Championed radical innovation for bringing to patients disease-modifying, paradigm-changing therapeutics such as siRNA, and led in a scientific and business manner Roche's global cell therapeutics strategy and implementation team resulting in Roche's entry in 2010 in the field of regenerative medicine.

. Member, Industry Committee-Europe, Tissue Engineering and Regenerative Medicine International Society

. Co-Editor, Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies (Wiley, 2015).

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/2784225
Adroll
adroll